Acquired haemophilia A (AHA) is caused by autoantibodies that neutralise Factor VIII (FVIII) and can cause severe bleeding. The COVID-19 vaccine may trigger the development of acquired autoantibodies ...

Medically reviewed by Steffini Stalos, DO Hemophilia disease is a rare inherited bleeding disorder. People with this genetic condition do not produce sufficient clotting factors, which can cause ...

When the disease appears later in life, it is referred to as acquired hemophilia. Appropriate treatment can control hemophilia in these instances. There is a possibility that the disease can ...

About 30% of people hospitalized due to acquired hemophilia have a bleeding event, while 17% have a blood clot-related ...

Hemophilia A can be hereditary or acquired. It is not curable, and several treatments are used to help prevent bleeding. This article will discuss the symptoms and causes of hemophilia A ...

The US Food and Drug Administration has approved fitusiran for bleeding prophylaxis in hemophilia A and B with or without ...

Hemophilia treatment market is driven by aging populations increasing acquired cases, government-backed early diagnosis, and ...

An estimated 7700 people in England have haemophilia A, with around 1900 classified as severe cases where their factor VIII activity level is less than 1%. Current treatments involve factor VIII ...

Haemophilia, an uncommon genetic disorder ... while factor XI resides on chromosome 4. Acquired variety, however, occurs in ...

About two-thirds of type A and B cases of hemophilia occur in people with a family history of the condition. It’s also possible to develop acquired hemophilia with no personal or family history ...